| RE50267 | Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto | May 18, 22 | Jan 14, 25 | Arena Pharmaceuticals Inc. |
| RE50250 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | Jul 15, 22 | Dec 31, 24 | Firmenich SA |
| RE50062 | Process for producing acetic acid | Dec 12, 19 | Jul 30, 24 | Daicel Corporation Industries Ltd. |
| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
| RE49932 | Energy source supply systems, energy source supply devices, and related methods | Aug 28, 20 | Apr 23, 24 | A3 LABS, LLC |
| RE49896 | Dehydrofluorination of 245FA to 1234ZE | Dec 09, 21 | Apr 02, 24 | THE CHEMOURS COMPANY FC, LLC |
| RE49897 | Salts of a dihydroquinazoline derivative | May 14, 21 | Apr 02, 24 | AIC246 AG & Co. KG |
| RE49849 | Processes for the production of fluoropropanes and halopropenes | Nov 25, 14 | Feb 27, 24 | THE CHEMOURS COMPANY FC, LLC |
| RE49811 | Sphingosine kinase inhibitors | Mar 07, 22 | Jan 23, 24 | Apogee Biotechnology Corporation |
| RE49610 | Heterogeneous catalyst for transesterification and method of preparing same | Sep 14, 20 | Aug 15, 23 | Crystaphase Products Inc. |
| RE49569 | Alkylamine derivative | Apr 01, 21 | Jul 04, 23 | EA PHARMA CO., LTD. |
| RE49551 | Heterogeneous catalyst for transesterification and method of preparing same | Sep 14, 20 | Jun 13, 23 | Crystaphase Products Inc. |
| RE49502 | Phenyl based compounds substituted with aldehyde moieties and their use in perfumery | Jul 07, 20 | Apr 25, 23 | Givaudan SA |
| RE49370 | Cyclic process for the production of taurine from monoethanolamine | Jun 08, 20 | Jan 17, 23 | Vitaworks IP, LLC |
| RE49240 | Inhibitors of histone deacetylase | Mar 11, 20 | Oct 11, 22 | The General Hospital Corporation |
| RE49238 | Alleviating oxidative stress disorders with PUFA derivatives | Aug 19, 20 | Oct 11, 22 | RETROTOPE, INC. |
| RE49233 | Ionizable cationic lipid for RNA delivery | Mar 12, 19 | Oct 04, 22 | Arcturus Therapeutics, Inc. |
| RE49222 | Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same | Oct 30, 19 | Sep 27, 22 | DAIKIN INDUSTRIES, LTD.; Osaka University; |
| RE49223 | Water-soluble fluorescence compound and method for preparing the same | Apr 29, 20 | Sep 27, 22 | SNU R&DB Foundation; Global Frontier Center for Multiscale Energy Systems; |
| RE49036 | Method for synthesizing optically active carbonyl compounds | Jul 25, 19 | Apr 19, 22 | BASF SE |